Amgen 2012 Annual Report Download - page 89

82
Exhibit No. Description
3.6 Certificate of Amendment of Restated Certificate of Incorporation of Amgen Inc. (As Amended May 11,
2009). (Filed as an exhibit to Form 10-Q for the quarter ended June 30, 2009 on August 10, 2009 and
incorporated herein by reference.)
3.7 Certificate of Correction of Restated Certificate of Incorporation of Amgen Inc. (As Corrected May 11,
2009). (Filed as an exhibit to Form 10-Q for the quarter ended June 30, 2009 on August 10, 2009 and
incorporated herein by reference.)
3.8 Certificate of Correction of Restated Certificate of Incorporation of Amgen Inc. (As Corrected May 13,
2010). (Filed as an exhibit to Form 10-Q for the quarter ended June 30, 2010 on August 9, 2010 and
incorporated herein by reference.)
3.9 Certificate of Amendment of Restated Certificate of Incorporation of Amgen Inc. (As Amended May 23,
2012) (Filed as Appendix B to the Definitive Proxy Statement on Schedule 14A on April 12, 2012 and
incorporated herein by reference.)
3.10 Amended and Restated Bylaws of Amgen Inc. (As Amended and Restated October 6, 2009). (Filed as an
exhibit to Form 8-K filed on October 7, 2009 and incorporated herein by reference.)
3.11 First Amendment to the Amended and Restated Bylaws of Amgen Inc. (Filed as an exhibit to Form 8-K
filed on May 24, 2012 and incorporated herein by reference.)
4.1 Form of stock certificate for the common stock, par value $.0001 of the Company. (Filed as an exhibit to
Form 10-Q for the quarter ended March 31, 1997 on May 13, 1997 and incorporated herein by reference.)
4.2 Form of Indenture, dated January 1, 1992. (Filed as an exhibit to Form S-3 Registration Statement filed
on December 19, 1991 and incorporated herein by reference.)
4.3 Agreement of Resignation, Appointment and Acceptance dated February 15, 2008. (Filed as an exhibit to
Form 10-K for the year ended December 31, 2007 on February 28, 2008 and incorporated herein by
reference.)
4.4 First Supplemental Indenture, dated February 26, 1997. (Filed as an exhibit to Form 8-K on March 14,
1997 and incorporated herein by reference.)
4.5 8-1/8% Debentures due April 1, 2097. (Filed as an exhibit to Form 8-K filed on April 8, 1997 and
incorporated herein by reference.)
4.6 Officer’ s Certificate, dated as of January 1, 1992, as supplemented by the First Supplemental Indenture,
dated as of February 26, 1997, establishing a series of securities entitled “8 1/8% Debentures due April 1,
2097.” (Filed as an exhibit to Form 8-K filed on April 8, 1997 and incorporated herein by reference.)
4.7 Indenture, dated as of August 4, 2003. (Filed as an exhibit to Form S-3 Registration Statement on August
4, 2003 and incorporated herein by reference.)
4.8 Form of 4.85% Senior Notes due 2014. (Filed as an exhibit to Form 8-K on November 19, 2004 and
incorporated herein by reference.)
4.9 Officers’ Certificate, dated November 18, 2004, including forms of the 4.00% Senior Notes due 2009 and
4.85% Senior Notes due 2014. (Filed as an exhibit to Form 8-K on November 19, 2004 and incorporated
herein by reference.)
4.10 Indenture, dated as of February 17, 2006 and First Supplemental Indenture, dated as of June 8, 2006
(including form of 0.375% Convertible Senior Note due 2013). (Filed as exhibit to Form 10-Q for the
quarter ended June 30, 2006 on August 9, 2006 and incorporated herein by reference.)
4.11 Corporate Commercial Paper - Master Note between and among Amgen Inc., as Issuer, Cede & Co., as
Nominee of The Depository Trust Company, and Citibank, N.A., as Paying Agent. (Filed as an exhibit to
Form 10-Q for the quarter ended March 31, 1998 on May 13, 1998 and incorporated herein by reference.)
4.12 Officers’ Certificate of Amgen Inc., dated as of May 30, 2007, including forms of the Company’s Senior
Floating Rate Notes due 2008, 5.85% Senior Notes due 2017 and 6.375% Senior Notes due 2037. (Filed
as an exhibit to Form 8-K on May 30, 2007 and incorporated herein by reference.)